CSBR

Champions Oncology Inc

4.79

Nov 06 • 3:59 PM ET +0.03 (0.63%)

4.83

Aftermarket • 4:15 PM ET +0.04 (0.84%)

Healthcare Biotechnology USA Micro NASD

Peers: CRL FTRE CAI MEDP TEM NEO ICLR CERT PSNL AZTA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-
Market Cap	66.67M
Enterprise Value	73.85M
Income	-1.10M
Sales	60.66M
Book/sh	0.28
Cash/sh	0.31
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	214
IPO	Jun 15, 1992

P/E	-
Forward P/E	-
PEG	-
P/S	1.10
P/B	17.13
P/C	15.29
P/FCF	-
EV/EBITDA	205.13
EV/Sales	1.22
Quick Ratio	1.03
Current Ratio	1.03
Debt/Eq	2.82
LT Debt/Eq	2.60
Option/Short	Yes / Yes

EPS (ttm)	-0.08
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	40.02% -
Sales past 3/5Y	3.33% 7.68%
EPS Y/Y TTM	-136.61%
Sales Y/Y TTM	6.65%
EPS Q/Q	3.16%
Sales Q/Q	8.84%
Earnings	Sep 10 AMC
EPS/Sales Surpr.	- -

Insider Own	56.62%
Insider Trans	0.00%
Inst Own	18.81%
Inst Trans	-46.75%
ROA	-3.46%
ROE	-29.83%
ROIC	-7.89%
Gross Margin	47.69%
Oper. Margin	-1.54%
Profit Margin	-1.82%
SMA20	-0.45%
SMA50	-2.93%
SMA200	-15.79%
Trades

Shs Outstand	13.92M
Shs Float	6.04M
Short Float	1.29%
Short Ratio	7.28
Short Interest	0.08M
52W High	8.31 -42.36%
52W Low	4.59 4.36%
Volatility	3.93% 3.88%
ATR (14)	0.20
RSI (14)	46.04
Beta	0.45
Rel Volume	0.40
Avg Volume	10.67K
Volume	4,255

Perf Week	-0.42%
Perf Month	-3.82%
Perf Quarter	-6.81%
Perf Half Y	-20.43%
Perf YTD	-30.68%
Perf Year	-30.38%
Perf 3Y	-15.96%
Perf 5Y	-52.57%
Perf 10Y	199.37%
Recom	1.00
Target Price	12.00
Prev Close	4.76
Price	4.79
Change %	0.63%

Consensus

Strong Buy

Avg. Price Target

$12.00

Implied Upside

+150.5%

Analysts2incl. previous ratings

Rating Distribution2 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 12, 2024	Upgrade	CCraig Hallum	Hold → Buy	$6	+25.3%
Nov 18, 2019	Initiated	TThe Benchmark Company	Speculative Buy

Sep-14-26 09:00PM	Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ... (GuruFocus.com)
Sep-10-26 04:00PM	Champions Oncology Reports Revenue of $15.2 Million (ACCESSWIRE)
Sep-04-26 11:15AM	Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026 (ACCESSWIRE)
Sep-01-26 09:00AM	Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging (ACCESSWIRE)
Jul-29-26 11:00PM	Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ... (GuruFocus.com)
04:00PM	Loading…
Jul-27-26 04:00PM	Champions Oncology Reports Record Annual Revenue of $59 Million (ACCESSWIRE) -8.75%
Jul-20-26 04:30PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026 (ACCESSWIRE)
Apr-09-26 01:40PM	Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026 (ACCESSWIRE)
Mar-30-26 10:55AM	Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy (ACCESSWIRE)
Mar-18-26 09:00PM	Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ... (GuruFocus.com) -5.97% +6.35%
Mar-12-26 04:01PM	Champions Oncology Reports Revenue of $16.6 Million (ACCESSWIRE) +6.27%
Mar-05-26 04:00PM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 (ACCESSWIRE)
Dec-16-25 12:00AM	Champions Oncology Inc (CSBR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) -13.72%
Dec-15-25 04:00PM	Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million (ACCESSWIRE) +16.07%
Dec-08-25 04:00PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025 (ACCESSWIRE)
03:01AM	Loading…
Sep-16-25 03:01AM	Champions Oncology Inc (CSBR) Q1 2026 Earnings Call Highlights: Revenue Rebound and Strategic ... (GuruFocus.com) -16.02%
Sep-15-25 04:50PM	CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million (ACCESSWIRE) +21.52%
03:55PM	Champions Oncology Reports Record Quarterly Revenue of $14.0 Million (ACCESSWIRE)
Sep-10-25 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025 (ACCESSWIRE)
Jul-24-25 03:11AM	Champions Oncology Inc (CSBR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -14.19%
Jul-23-25 04:00PM	Champions Oncology Reports Record Annual Revenue of $57 Million (ACCESSWIRE)
Jul-21-25 08:30AM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025 (ACCESSWIRE)
Jul-18-25 08:30AM	Champions Oncology Announces Appointment of New CEO (ACCESSWIRE)
Jul-08-25 08:30AM	Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models (ACCESSWIRE)
Apr-28-25 09:45AM	Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House (ACCESSWIRE) -7.47%
Apr-24-25 08:00AM	Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine (ACCESSWIRE)
Apr-21-25 04:20PM	Champions Oncology Inc (CSBR) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Mar-11-25 03:55PM	Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million (ACCESSWIRE) +10.00%
Mar-06-25 04:00PM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 (ACCESSWIRE)
Feb-18-25 09:00AM	Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting (ACCESSWIRE)
03:47PM	Loading…
Feb-14-25 03:47PM	Schrodinger Stock Scores IBD Rating Upgrade (Investor's Business Daily)
Jan-09-25 08:30AM	Champions Oncology integrates Cytek Aurora flow cytometers (TipRanks)
Jan-08-25 08:00AM	Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership (ACCESSWIRE) -8.00%
Dec-11-24 04:00PM	Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million (ACCESSWIRE) +12.09% -11.64%
Dec-05-24 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 (ACCESSWIRE) +6.22%
Oct-16-24 10:55AM	Champions Oncology Announces Agreement with Weill Cornell Medicine (ACCESSWIRE)
Oct-09-24 07:00PM	Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:05PM	Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Sep-12-24 08:03AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript (Insider Monkey) +9.58%
Sep-11-24 04:00PM	Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million (ACCESSWIRE)
Sep-09-24 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 (ACCESSWIRE) -6.62%
Jul-18-24 09:53PM	CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
04:00PM	Champions Oncology Reports Quarterly Revenue of $14.0 Million (ACCESSWIRE)
Jul-11-24 04:05PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 (ACCESSWIRE)
Jun-04-24 09:00AM	Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development (ACCESSWIRE)
Mar-19-24 08:28AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Mar-12-24 04:30PM	Champions Oncology Reports Quarterly Revenue of $12.0 Million (ACCESSWIRE)
Mar-07-24 09:00AM	Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation (ACCESSWIRE)
Mar-06-24 04:35PM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 (ACCESSWIRE)
Dec-14-23 08:22AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript (Insider Monkey)
Dec-12-23 09:54PM	CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -6.49% +5.42%
04:00PM	Champions Oncology Reports Quarterly Revenue of $11.6 Million (ACCESSWIRE)
Dec-04-23 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023 (ACCESSWIRE)
Nov-02-23 08:30AM	Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification (ACCESSWIRE)
Oct-17-23 08:30AM	Champions Oncology Announces the Addition of Brady Davis as President (ACCESSWIRE)
Sep-13-23 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.6 Million (ACCESSWIRE) -16.29%
Sep-11-23 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023 (ACCESSWIRE)
Aug-22-23 08:30AM	Champions Oncology Announces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023 (ACCESSWIRE)
Aug-01-23 08:45AM	Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies (ACCESSWIRE)
Jul-24-23 04:00PM	Champions Oncology Reports Quarterly Revenue of $13.1 Million (ACCESSWIRE) -8.03%
Jul-20-23 04:00PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 (ACCESSWIRE)
Apr-17-23 08:30AM	Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development (ACCESSWIRE) +8.54%
Apr-05-23 09:50AM	Champions Oncology Announces $5M Stock Repurchase Program (ACCESSWIRE) +5.26%
Mar-15-23 03:50PM	Champions Oncology Reports Quarterly Revenue of $12.8 Million (ACCESSWIRE)
Mar-13-23 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023 (ACCESSWIRE)
Dec-16-22 08:48AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2023 Earnings Call Transcript (Insider Monkey) -10.91%
Dec-13-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $14.3 Million (ACCESSWIRE) +5.21% -31.04%
Dec-09-22 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 (ACCESSWIRE)
Sep-08-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $13.7 Million (ACCESSWIRE)
Sep-06-22 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022 (ACCESSWIRE) -5.38%
Aug-15-22 08:08AM	What Type Of Shareholders Make Up Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Registry? (Simply Wall St.)
Jul-23-22 09:57AM	We Ran A Stock Scan For Earnings Growth And Champions Oncology (NASDAQ:CSBR) Passed With Ease (Simply Wall St.)
Jul-21-22 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.9 Million (ACCESSWIRE) +8.12%
Jul-14-22 04:00PM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 (ACCESSWIRE)
Jun-13-22 06:30AM	Investors in Champions Oncology (NASDAQ:CSBR) have made a impressive return of 197% over the past five years (Simply Wall St.)
May-31-22 08:30AM	Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics (ACCESSWIRE)
May-03-22 08:30AM	Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo (ACCESSWIRE)
May-02-22 01:16PM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? (Simply Wall St.)
Mar-15-22 04:45PM	Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million (ACCESSWIRE) +8.17%
Mar-11-22 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022 (ACCESSWIRE)
Mar-07-22 01:10PM	Do Institutions Own Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.)
Feb-15-22 08:30AM	Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors (ACCESSWIRE) +6.47%
Jan-20-22 08:30AM	Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates (ACCESSWIRE)
Jan-04-22 08:30AM	Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs (ACCESSWIRE)
05:07AM	Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their impressive 149% return over the last five years (Simply Wall St.)
Dec-13-21 04:20PM	Champions Oncology Reports Record Quarterly Revenue of $11.8 Million (ACCESSWIRE)
Dec-06-21 09:20AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021 (ACCESSWIRE)
Nov-05-21 08:24AM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? (Simply Wall St.)
Oct-20-21 10:25AM	Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus (ACCESSWIRE)
Sep-13-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $11.3 Million (ACCESSWIRE)
Sep-06-21 03:00PM	Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect (Zacks)
07:09AM	What Kind Of Shareholders Hold The Majority In Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares? (Simply Wall St.)
Sep-02-21 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021 (ACCESSWIRE) +5.49%
Jul-26-21 08:30AM	Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development (ACCESSWIRE)
Jul-22-21 08:00AM	Champions Oncology Reports Quarterly Revenue of $10.6 Million (ACCESSWIRE)
Jul-14-21 08:30AM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021 (ACCESSWIRE)
Jul-08-21 03:06AM	The Champions Oncology (NASDAQ:CSBR) Share Price Is Up 335% And Shareholders Are Delighted (Simply Wall St.)
Jun-15-21 09:00AM	Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions (ACCESSWIRE)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ACKERMAN JOEL	Director	Oct 15 '26	Option Exercise	1.60	69,794	111,670	1,126,333	Oct 16 12:45 PM

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Executive ChairDr. Ronnie Morris M.D.

CEO & DirectorMr. Robert Brainin

Chief Financial OfficerMr. David Barry Miller M.B.A.

Chief Operating OfficerDr. Maria Mancini Ph.D.

Executive Vice President of GrowthDr. Marianna Zipeto Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CSBR

Champions Oncology Inc

Upgrade your Finviz experience